Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
PaperCitations, authors & open-access status
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 335 citations, 2015 year and closed oa status.
335
Citations
2015
Year
closed
OA Status